SpaceX Valuation Doubts Rise as Damodaran Declares It 'Too Richly Priced'
Fazen Markets Editorial Desk
Collective editorial team · methodology
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Renowned New York University finance professor Aswath Damodaran stated on June 7, 2026, that he is not buying into SpaceX, calling the company 'too richly priced.' Damodaran, often referred to as the 'Dean of Valuation,' said he understands the speculative appeal but positions himself as a cautious investor over a trader. The commentary arrives as SpaceX's latest private funding round reportedly values the Elon Musk-led aerospace firm at approximately $180 billion, a level that has drawn increased scrutiny from fundamental analysts. This valuation implies a revenue multiple exceeding 10x on projected 2026 sales, a significant premium to both public aerospace peers and high-growth tech companies.
Private market valuations for venture-stage companies have faced pressure since the Federal Reserve's rate-hiking cycle began in 2022. The last major re-pricing for a mega-cap private firm occurred in 2023, when Swedish fintech Klarna saw its valuation cut 85% from a $45.6 billion peak to around $6.7 billion during a down round. The current macro backdrop features a Fed funds target range of 4.75%-5.00%, with 10-year Treasury yields stabilizing near 4.3%.
This environment demands greater cash flow discipline from growth companies. The catalyst for renewed valuation debate is SpaceX's accelerating capital expenditure cycle for its Starship program and Starlink constellation, paired with heightened anticipation of an eventual initial public offering. Investor impatience for liquidity events has grown as the IPO window for large, unprofitable tech firms remains constrained, increasing pressure to justify paper valuations with concrete financial metrics.
SpaceX's reported $180 billion valuation marks a 20% increase from its $150 billion valuation in a late-2024 funding round. The company's revenue is estimated to have grown to $15-$17 billion in 2025, primarily from Starlink subscriptions and launch services. This places its forward price-to-sales ratio between 10.6x and 12x.
For comparison, established public aerospace giant Lockheed Martin trades at a price-to-sales ratio of 1.8x. High-growth public tech company Rivian Automotive trades at 2.3x sales. Even within the private space sector, competitor Rocket Lab holds a public market capitalization of $2.1 billion against projected 2026 revenue of $1 billion, a 2.1x multiple.
| Metric | SpaceX (Private) | Rocket Lab (Public RKLB) | S&P 500 Aerospace & Defense Index |
|---|---|---|---|
| Estimated P/S Ratio (2026) | 10.6x - 12x | ~2.1x | ~1.9x |
| Revenue Growth Est. (2026) | ~40% | ~30% | ~5% |
SpaceX has raised over $10 billion in equity funding since its founding. The company's Starlink division now serves over 3 million customers globally.
Damodaran's skepticism presents a headwind for the broader private space investment ecosystem. Publicly traded space-adjacent equities like satellite component maker ViaSat (VSAT) and geospatial data provider Planet Labs (PL) may face multiple compression if investor appetite for growth-at-any-price narratives wanes. These stocks are down 12% and 18% year-to-date, respectively, underperforming the Nasdaq's 8% gain.
The primary counter-argument is that SpaceX's valuation captures optionality on monopolistic markets—global satellite broadband and point-to-point space transport—that traditional multiples fail to price. Proponents argue that comparing SpaceX to legacy aerospace is flawed due to its vertically integrated, reusable launch technology which drastically reduces cost.
Positioning data shows venture capital and growth equity funds remain net long the space sector, but hedge fund short interest in public aerospace and satellite stocks has increased by 22% over the last quarter. Flow is rotating toward companies with proven free cash flow, like Northrop Grumman (NOC) and L3Harris Technologies (LHX), which yield 1.7% and 2.1% respectively.
The next major catalyst for SpaceX valuation is the Q3 2026 earnings report from Tesla (TSLA), due around July 23. As CEO Elon Musk's largest liquid asset, Tesla stock performance directly impacts his ability to fund SpaceX ambitions without further dilutive private raises. A significant decline in Tesla's market cap could tighten funding conditions for SpaceX.
Key levels to watch include the 10-year Treasury yield breaching 4.5%, which would further pressure high-duration growth asset valuations. The next Starship integrated flight test, currently scheduled for August 2026, represents a binary technical catalyst. Success could temporarily bolster sentiment, while failure may amplify cost and timeline concerns.
Regulatory decisions on Starlink spectrum allocation by the FCC, expected by late 2026, will materially impact the division's addressable market and competitive moat against rivals like Amazon's Project Kuiper.
Retail investors cannot directly purchase SpaceX shares, as it remains a private company. However, the valuation critique signals broader caution toward high-growth, pre-IPO assets accessible via special purpose acquisition companies (SPACs) or venture capital funds. It underscores the importance of fundamental metrics like price-to-sales ratios, even for disruptive stories. Retail exposure often comes through public stocks like ARK Space Exploration & Innovation ETF (ARKX), which holds SpaceX suppliers and may see correlated sentiment shifts.
Tesla reached a market capitalization of $30 billion in early 2017, roughly eight years after its founding, on approximately $7 billion in annual revenue—a P/S ratio near 4.3x. SpaceX, at a similar stage since its 2002 founding, commands a valuation six times larger on a revenue base only twice as big, implying a much richer multiple. Tesla’s path to profitability was clearer with a tangible consumer product, whereas SpaceX's largest revenue driver, Starlink, faces significant ongoing capital deployment and competitive risks.
During the 2021 market peak, software-as-a-service (SaaS) companies like Snowflake (SNOW) traded at P/S ratios above 40x. The median for high-growth tech has since normalized to approximately 6x. A 10x-12x sales multiple today is reserved for companies with demonstrable >50% annual growth, clear paths to >30% operating margins, and large total addressable markets. Historical precedent shows such premiums are unsustainable without sequential quarters of execution; most companies that failed to deliver saw multiples halve within 18 months.
A premier valuation authority's refusal to endorse SpaceX's $180 billion price tag signals a maturity check for speculative growth investing reliant on distant profitability.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.